PIV

Express Learning Breakout

(I5) Peripheral Intravenous Devices in Cancer Care Services - Risk Factors for Failure

Presenter(s)

• 

  Emily Larsen, RN, BN, BHlthSci, GDipEnvHlth, GDipHlthRes

  Senior Research Assistant
  Griffith University

  Nothing to Disclose

Co-Presenter(s)

• 

  Nicole Marsh, RN, BN, MAdvPrac(HlthRes), PhD

  Research Fellow (Vascular Access)
  Royal Brisbane and Women's Hospital; Griffith University

  Angiodynamics: Grant/Research Support (Status: Ongoing)

Despite the complex treatment Oncology and Haematology patients require, and the frequent use of Central Venous Access Devices, the use of Peripheral Intravenous catheters (PIV) remains common. Specific risk factors contributing to PIV failure among Cancer Care patients are under-reported. Two hundred patients requiring a PIV upon admission to an Oncology or Haematology unit of a tertiary hospital were prospectively followed from admission through to discharge. Each PIV the patient received throughout this time was followed and documented to understand how risk factors, both modifiable (eg. PIV location) and non-modifiable (eg. gender), impacted upon the primary outcome - PIV failure. Furthermore, patients were interviewed about their PIV to understand the emotional and physical impact of PIV failure; and inform future research.

Learning Objectives:

• Describe what modifiable risk factors are associated with PIV failure in Cancer Care; and ways to mitigate them.
• Explain the impact of non-modifiable risk factors and how this should be influencing device and vein selection.
• Understand the patients’ experience of PIV within Cancer Care; and the importance of their inclusion in decision-making processes.